Nestlé Health Science to acquire the Mevalia® and ComidaMed® brands from Dr. Schär

 

Vitaflo (International) Limited, part of Nestlé Health Science, and Dr. Schär AG have entered into an agreement whereby Vitaflo will acquire the Dr. Schär products for Inborn Errors of Metabolism (IEM) as well as the manufacturing facility in Rosbach, Germany. The acquired brands, Mevalia® and ComidaMed®, are used for the dietary management of IEM and cow’s milk protein allergy and will complement Vitaflo’s existing IEM product portfolio and geographic footprint, offering more choice and variety to meet different customer needs.

“It can be very challenging for people to manage IEM dietary requirements on a day-to-day basis. Our mission is to make this as easy as possible, creating clinical nutrition products which taste great and are easy to incorporate into a busy life” said Caroline Charlesworth, CEO of Vitaflo. “Dr. Schär has been developing products for special nutritional needs for almost 100 years, combining special, complex dietary requirements with great taste and quality profiles. We look forward to incorporating the Mevalia® and ComidaMed® brands into our portfolio to bring IEM solutions to more people around the world, offering more choice and variety.”

“For almost 100 years we have committed to improve the lives of people with special nutritional needs. Nestlé Health Science shares our passion for health and wellbeing and with this integration of the business within Vitaflo we are positive that they will continue our successful journey in Metabolic Nutrition. This gives us the opportunity to focus even more on inclusive nutrition and gluten-free with the rest of our global brands portfolio,” said Philipp Schoeller, CEO of Dr. Schär AG.

The transaction is expected to close 1st July 2021. Financial details are not being disclosed.

 

About Nestlé Health Science and Vitaflo (International) Limited

Nestlé Health Science, a leader in the science of nutrition, is a globally managed business unit of Nestlé. We are committed to redefining the management of health, offering an extensive portfolio of science-based consumer health, medical nutrition, pharmaceutical therapies, and vitamin and supplement brands. Our extensive research network provides the foundation for products that empower healthier lives through nutrition. Headquartered in Switzerland, we have more than 7,000 employees around the world, with products available in more than 140 countries. www.nestlehealthscience.com

Vitaflo is a business unit of Nestlé Health Science with a global footprint. For over 20 years, Vitaflo has been at the forefront of developing innovative specialised clinical nutrition products for Inborn Errors of Metabolism, nutrition support and disease specific conditions.

Vitaflo

About Dr. Schär AG


Our story began in 1922 in South Tyrol, the heart of the Alps, with a vision to improve the lives of people with special nutritional needs. Ever since the company was founded, proximity to the consumer has been our guiding commitment. Our core competence combines the specific, complex requirements placed on nutrition with dedication and joie de vivre. Responsibility, progress and proximity are the values that give us our stability and reliability. We are a family-run company with a global reach, with 18 sites in 11 countries and more than 1,400 employees worldwide. Our products are available in about 100 countries. www.drschaer.com


Media contact:

Vitaflo (International) Limited

Olivia Carty

Tel: +44 (0) 151 709 9020

E-Mail: olivia.carty@vitaflo.co.uk

 

Dr. Schär AG / SPA

Winkelau 9

39014 Burgstall / Postal

Italien

Victoria Angerer

Telefon: +39473293302

E-Mail: Victoria.Angerer@drschaer.com